Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	Period 1: Initital 2-week Treatment - Amisulpride Treated Patients	0	163
Total, all-cause mortality	Period 1: Initital 2-week Treatment - Olanzapine Treated Patients	1	164
Total, all-cause mortality	Period 2: Extended 6-week Treatment - Early Responders	1	140
Total, all-cause mortality	Period 2: Extended 6-week Treatment - Early Non-responders Switched	0	70
Total, all-cause mortality	Period 2: Extended 6-week Treatment - Early Non-responders Not Switched	0	72
Total, other adverse events	Period 1: Initital 2-week Treatment - Amisulpride Treated Patients	36	163
Total, other adverse events	Period 1: Initital 2-week Treatment - Olanzapine Treated Patients	33	164
Total, other adverse events	Period 2: Extended 6-week Treatment - Early Responders	32	140
Total, other adverse events	Period 2: Extended 6-week Treatment - Early Non-responders Switched	21	70
Total, other adverse events	Period 2: Extended 6-week Treatment - Early Non-responders Not Switched	7	72
Total, serious adverse events	Period 1: Initital 2-week Treatment - Amisulpride Treated Patients	3	163
Total, serious adverse events	Period 1: Initital 2-week Treatment - Olanzapine Treated Patients	3	164
Total, serious adverse events	Period 2: Extended 6-week Treatment - Early Responders	7	140
Total, serious adverse events	Period 2: Extended 6-week Treatment - Early Non-responders Switched	5	70
Total, serious adverse events	Period 2: Extended 6-week Treatment - Early Non-responders Not Switched	4	72

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01029769/event-totals